ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Vaccine Contract Manufacturing Market Research Report 2024
Published Date: May 2024
|
Report Code: QYRE-Auto-20G17482
Home | Market Reports | Law & Government| Public Safety
Global Human Vaccine Contract Manufacturing Market Research Report 2024
BUY CHAPTERS

Global Human Vaccine Contract Manufacturing Market Research Report 2024

Code: QYRE-Auto-20G17482
Report
May 2024
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Government
Lonza
FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
Ajinomoto Althea, Inc.
Merck KGaA
Cytovance Biologics
Catalent
IDT Biologika GmbH
Albany Molecular Research Inc
PRA Health Sciences
ICON
Pharmaceutical Product Development LLC
Cobra Bio
Paragon Bioservices, Inc.
Emergent BioSolutions Inc
CSL Limited
BioNTech SE
Wuxi Biologics
Samsung Biologics
Boehringer Ingelheim
Novavax Inc

Human Vaccine Contract Manufacturing Market Size

The global Human Vaccine Contract Manufacturing market was valued at US$ 6013 million in 2023 and is anticipated to reach US$ 12610 million by 2030, witnessing a CAGR of 11.1% during the forecast period 2024-2030.

Human Vaccine Contract Manufacturing Market

Human Vaccine Contract Manufacturing Market

The vaccine contract manufacturing sector pertains to the domain where pharmaceutical firms enlist the services of external contract manufacturing entities for the production of vaccines. These contract manufacturing organizations (CMOs) possess the requisite infrastructure, specialized know-how, and dedicated facilities to manufacture vaccines on behalf of the original developers. Contract manufacturers specializing in human use applications are well-equipped to meet the stringent regulatory requirements and quality standards governing vaccine production for human use.
Market CAGR for vaccine contract manufacturing is being driven by the rising vaccination rates worldwide. In the ever-evolving landscape of governmental and healthcare endeavors aimed at bolstering immunization coverage against the backdrop of infectious maladies, a pressing imperative emerges—a dire necessity for the expansion of vaccine production capacity. Within this exigent milieu, contract manufacturers emerge as veritable linchpins, wielding their prowess in the domain of vaccine production to furnish a panacea of flexible and scalable manufacturing solutions. Endowed with specialized facilities and unwavering fidelity to regulatory strictures, these entities furnish pharmaceutical behemoths with the instrumental means to orchestrate a seamless augmentation of vaccine production capabilities. The harrowing specter of the COVID-19 pandemic has served to magnify the imperative of fortifying vaccine manufacturing prowess, propelling a surge in investments geared towards the fecundation of vaccine development and production endeavors. As the apogee of vaccination rates is charted across the global expanse, the clamor for the services rendered by vaccine contract manufacturers is poised to ascend to vertiginous heights, heralding an epoch of unprecedented market growth. Enmeshed within the tapestry of the Vaccine Contract Manufacturing Market are the sinews of global health exigencies, wherein the specter of infectious disease outbreaks and the omnipresent shadow of pandemics serve as vanguards propelling the market's ascension. The burgeoning ubiquity of infectious pathogens, intertwined with the looming specter of bioterrorism, accentuates the exigency of vaccines as sentinels of public health. In this crucible of exigency, contract manufacturers emerge as valiant custodians, orchestrating a symphony of vaccine manufacturing prowess to assuage the tremors of global health crises.
This report aims to provide a comprehensive presentation of the global market for Human Vaccine Contract Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Vaccine Contract Manufacturing.
The Human Vaccine Contract Manufacturing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Vaccine Contract Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Vaccine Contract Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Human Vaccine Contract Manufacturing Market Report

Report Metric Details
Report Name Human Vaccine Contract Manufacturing Market
Accounted market size in 2023 US$ 6013 million
Forecasted market size in 2030 US$ 12610 million
CAGR 11.1%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Attenuated
  • Inactivated
  • Subunit-based
  • Toxoid-based
  • DNA-based
Segment by Application
  • Downstream
  • Upstream
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Lonza, Fujifilm Diosynth Biotechnologies U.S.A., Inc., Ajinomoto Althea, Inc., Merck KgaA, Cytovance Biologics, Catalent, Inc., IDT Biologika GmbH, Albany Molecular Research, Inc., PRA Health Sciences, ICON plc., Pharmaceutical Product Development, LLC, Cobra Bio, Paragon Bioservices, Inc., Emergent BioSolutions Inc., CSL Limited, BioNTech SE, Wuxi Biologics, Samsung Biologics, Boehringer Ingelheim, Novavax, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Human Vaccine Contract Manufacturing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Human Vaccine Contract Manufacturing Market growing?

Ans: The Human Vaccine Contract Manufacturing Market witnessing a CAGR of 11.1% during the forecast period 2024-2030.

What is the Human Vaccine Contract Manufacturing Market size in 2030?

Ans: The Human Vaccine Contract Manufacturing Market size in 2030 will be US$ 12610 million.

Who are the main players in the Human Vaccine Contract Manufacturing Market report?

Ans: The main players in the Human Vaccine Contract Manufacturing Market are Lonza, Fujifilm Diosynth Biotechnologies U.S.A., Inc., Ajinomoto Althea, Inc., Merck KgaA, Cytovance Biologics, Catalent, Inc., IDT Biologika GmbH, Albany Molecular Research, Inc., PRA Health Sciences, ICON plc., Pharmaceutical Product Development, LLC, Cobra Bio, Paragon Bioservices, Inc., Emergent BioSolutions Inc., CSL Limited, BioNTech SE, Wuxi Biologics, Samsung Biologics, Boehringer Ingelheim, Novavax, Inc.

What are the Application segmentation covered in the Human Vaccine Contract Manufacturing Market report?

Ans: The Applications covered in the Human Vaccine Contract Manufacturing Market report are Downstream, Upstream

What are the Type segmentation covered in the Human Vaccine Contract Manufacturing Market report?

Ans: The Types covered in the Human Vaccine Contract Manufacturing Market report are Attenuated, Inactivated, Subunit-based, Toxoid-based, DNA-based

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Vaccine Contract Manufacturing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Attenuated
1.2.3 Inactivated
1.2.4 Subunit-based
1.2.5 Toxoid-based
1.2.6 DNA-based
1.3 Market by Application
1.3.1 Global Human Vaccine Contract Manufacturing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Downstream
1.3.3 Upstream
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Vaccine Contract Manufacturing Market Perspective (2019-2030)
2.2 Global Human Vaccine Contract Manufacturing Growth Trends by Region
2.2.1 Global Human Vaccine Contract Manufacturing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Human Vaccine Contract Manufacturing Historic Market Size by Region (2019-2024)
2.2.3 Human Vaccine Contract Manufacturing Forecasted Market Size by Region (2025-2030)
2.3 Human Vaccine Contract Manufacturing Market Dynamics
2.3.1 Human Vaccine Contract Manufacturing Industry Trends
2.3.2 Human Vaccine Contract Manufacturing Market Drivers
2.3.3 Human Vaccine Contract Manufacturing Market Challenges
2.3.4 Human Vaccine Contract Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Vaccine Contract Manufacturing Players by Revenue
3.1.1 Global Top Human Vaccine Contract Manufacturing Players by Revenue (2019-2024)
3.1.2 Global Human Vaccine Contract Manufacturing Revenue Market Share by Players (2019-2024)
3.2 Global Human Vaccine Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Human Vaccine Contract Manufacturing Revenue
3.4 Global Human Vaccine Contract Manufacturing Market Concentration Ratio
3.4.1 Global Human Vaccine Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Vaccine Contract Manufacturing Revenue in 2023
3.5 Global Key Players of Human Vaccine Contract Manufacturing Head office and Area Served
3.6 Global Key Players of Human Vaccine Contract Manufacturing, Product and Application
3.7 Global Key Players of Human Vaccine Contract Manufacturing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Vaccine Contract Manufacturing Breakdown Data by Type
4.1 Global Human Vaccine Contract Manufacturing Historic Market Size by Type (2019-2024)
4.2 Global Human Vaccine Contract Manufacturing Forecasted Market Size by Type (2025-2030)
5 Human Vaccine Contract Manufacturing Breakdown Data by Application
5.1 Global Human Vaccine Contract Manufacturing Historic Market Size by Application (2019-2024)
5.2 Global Human Vaccine Contract Manufacturing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Human Vaccine Contract Manufacturing Market Size (2019-2030)
6.2 North America Human Vaccine Contract Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Human Vaccine Contract Manufacturing Market Size by Country (2019-2024)
6.4 North America Human Vaccine Contract Manufacturing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Vaccine Contract Manufacturing Market Size (2019-2030)
7.2 Europe Human Vaccine Contract Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Human Vaccine Contract Manufacturing Market Size by Country (2019-2024)
7.4 Europe Human Vaccine Contract Manufacturing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Vaccine Contract Manufacturing Market Size (2019-2030)
8.2 Asia-Pacific Human Vaccine Contract Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Human Vaccine Contract Manufacturing Market Size by Region (2019-2024)
8.4 Asia-Pacific Human Vaccine Contract Manufacturing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Vaccine Contract Manufacturing Market Size (2019-2030)
9.2 Latin America Human Vaccine Contract Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Human Vaccine Contract Manufacturing Market Size by Country (2019-2024)
9.4 Latin America Human Vaccine Contract Manufacturing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Vaccine Contract Manufacturing Market Size (2019-2030)
10.2 Middle East & Africa Human Vaccine Contract Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Human Vaccine Contract Manufacturing Market Size by Country (2019-2024)
10.4 Middle East & Africa Human Vaccine Contract Manufacturing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Human Vaccine Contract Manufacturing Introduction
11.1.4 Lonza Revenue in Human Vaccine Contract Manufacturing Business (2019-2024)
11.1.5 Lonza Recent Development
11.2 Fujifilm Diosynth Biotechnologies U.S.A., Inc.
11.2.1 Fujifilm Diosynth Biotechnologies U.S.A., Inc. Company Details
11.2.2 Fujifilm Diosynth Biotechnologies U.S.A., Inc. Business Overview
11.2.3 Fujifilm Diosynth Biotechnologies U.S.A., Inc. Human Vaccine Contract Manufacturing Introduction
11.2.4 Fujifilm Diosynth Biotechnologies U.S.A., Inc. Revenue in Human Vaccine Contract Manufacturing Business (2019-2024)
11.2.5 Fujifilm Diosynth Biotechnologies U.S.A., Inc. Recent Development
11.3 Ajinomoto Althea, Inc.
11.3.1 Ajinomoto Althea, Inc. Company Details
11.3.2 Ajinomoto Althea, Inc. Business Overview
11.3.3 Ajinomoto Althea, Inc. Human Vaccine Contract Manufacturing Introduction
11.3.4 Ajinomoto Althea, Inc. Revenue in Human Vaccine Contract Manufacturing Business (2019-2024)
11.3.5 Ajinomoto Althea, Inc. Recent Development
11.4 Merck KgaA
11.4.1 Merck KgaA Company Details
11.4.2 Merck KgaA Business Overview
11.4.3 Merck KgaA Human Vaccine Contract Manufacturing Introduction
11.4.4 Merck KgaA Revenue in Human Vaccine Contract Manufacturing Business (2019-2024)
11.4.5 Merck KgaA Recent Development
11.5 Cytovance Biologics
11.5.1 Cytovance Biologics Company Details
11.5.2 Cytovance Biologics Business Overview
11.5.3 Cytovance Biologics Human Vaccine Contract Manufacturing Introduction
11.5.4 Cytovance Biologics Revenue in Human Vaccine Contract Manufacturing Business (2019-2024)
11.5.5 Cytovance Biologics Recent Development
11.6 Catalent, Inc.
11.6.1 Catalent, Inc. Company Details
11.6.2 Catalent, Inc. Business Overview
11.6.3 Catalent, Inc. Human Vaccine Contract Manufacturing Introduction
11.6.4 Catalent, Inc. Revenue in Human Vaccine Contract Manufacturing Business (2019-2024)
11.6.5 Catalent, Inc. Recent Development
11.7 IDT Biologika GmbH
11.7.1 IDT Biologika GmbH Company Details
11.7.2 IDT Biologika GmbH Business Overview
11.7.3 IDT Biologika GmbH Human Vaccine Contract Manufacturing Introduction
11.7.4 IDT Biologika GmbH Revenue in Human Vaccine Contract Manufacturing Business (2019-2024)
11.7.5 IDT Biologika GmbH Recent Development
11.8 Albany Molecular Research, Inc.
11.8.1 Albany Molecular Research, Inc. Company Details
11.8.2 Albany Molecular Research, Inc. Business Overview
11.8.3 Albany Molecular Research, Inc. Human Vaccine Contract Manufacturing Introduction
11.8.4 Albany Molecular Research, Inc. Revenue in Human Vaccine Contract Manufacturing Business (2019-2024)
11.8.5 Albany Molecular Research, Inc. Recent Development
11.9 PRA Health Sciences
11.9.1 PRA Health Sciences Company Details
11.9.2 PRA Health Sciences Business Overview
11.9.3 PRA Health Sciences Human Vaccine Contract Manufacturing Introduction
11.9.4 PRA Health Sciences Revenue in Human Vaccine Contract Manufacturing Business (2019-2024)
11.9.5 PRA Health Sciences Recent Development
11.10 ICON plc.
11.10.1 ICON plc. Company Details
11.10.2 ICON plc. Business Overview
11.10.3 ICON plc. Human Vaccine Contract Manufacturing Introduction
11.10.4 ICON plc. Revenue in Human Vaccine Contract Manufacturing Business (2019-2024)
11.10.5 ICON plc. Recent Development
11.11 Pharmaceutical Product Development, LLC
11.11.1 Pharmaceutical Product Development, LLC Company Details
11.11.2 Pharmaceutical Product Development, LLC Business Overview
11.11.3 Pharmaceutical Product Development, LLC Human Vaccine Contract Manufacturing Introduction
11.11.4 Pharmaceutical Product Development, LLC Revenue in Human Vaccine Contract Manufacturing Business (2019-2024)
11.11.5 Pharmaceutical Product Development, LLC Recent Development
11.12 Cobra Bio
11.12.1 Cobra Bio Company Details
11.12.2 Cobra Bio Business Overview
11.12.3 Cobra Bio Human Vaccine Contract Manufacturing Introduction
11.12.4 Cobra Bio Revenue in Human Vaccine Contract Manufacturing Business (2019-2024)
11.12.5 Cobra Bio Recent Development
11.13 Paragon Bioservices, Inc.
11.13.1 Paragon Bioservices, Inc. Company Details
11.13.2 Paragon Bioservices, Inc. Business Overview
11.13.3 Paragon Bioservices, Inc. Human Vaccine Contract Manufacturing Introduction
11.13.4 Paragon Bioservices, Inc. Revenue in Human Vaccine Contract Manufacturing Business (2019-2024)
11.13.5 Paragon Bioservices, Inc. Recent Development
11.14 Emergent BioSolutions Inc.
11.14.1 Emergent BioSolutions Inc. Company Details
11.14.2 Emergent BioSolutions Inc. Business Overview
11.14.3 Emergent BioSolutions Inc. Human Vaccine Contract Manufacturing Introduction
11.14.4 Emergent BioSolutions Inc. Revenue in Human Vaccine Contract Manufacturing Business (2019-2024)
11.14.5 Emergent BioSolutions Inc. Recent Development
11.15 CSL Limited
11.15.1 CSL Limited Company Details
11.15.2 CSL Limited Business Overview
11.15.3 CSL Limited Human Vaccine Contract Manufacturing Introduction
11.15.4 CSL Limited Revenue in Human Vaccine Contract Manufacturing Business (2019-2024)
11.15.5 CSL Limited Recent Development
11.16 BioNTech SE
11.16.1 BioNTech SE Company Details
11.16.2 BioNTech SE Business Overview
11.16.3 BioNTech SE Human Vaccine Contract Manufacturing Introduction
11.16.4 BioNTech SE Revenue in Human Vaccine Contract Manufacturing Business (2019-2024)
11.16.5 BioNTech SE Recent Development
11.17 Wuxi Biologics
11.17.1 Wuxi Biologics Company Details
11.17.2 Wuxi Biologics Business Overview
11.17.3 Wuxi Biologics Human Vaccine Contract Manufacturing Introduction
11.17.4 Wuxi Biologics Revenue in Human Vaccine Contract Manufacturing Business (2019-2024)
11.17.5 Wuxi Biologics Recent Development
11.18 Samsung Biologics
11.18.1 Samsung Biologics Company Details
11.18.2 Samsung Biologics Business Overview
11.18.3 Samsung Biologics Human Vaccine Contract Manufacturing Introduction
11.18.4 Samsung Biologics Revenue in Human Vaccine Contract Manufacturing Business (2019-2024)
11.18.5 Samsung Biologics Recent Development
11.19 Boehringer Ingelheim
11.19.1 Boehringer Ingelheim Company Details
11.19.2 Boehringer Ingelheim Business Overview
11.19.3 Boehringer Ingelheim Human Vaccine Contract Manufacturing Introduction
11.19.4 Boehringer Ingelheim Revenue in Human Vaccine Contract Manufacturing Business (2019-2024)
11.19.5 Boehringer Ingelheim Recent Development
11.20 Novavax, Inc.
11.20.1 Novavax, Inc. Company Details
11.20.2 Novavax, Inc. Business Overview
11.20.3 Novavax, Inc. Human Vaccine Contract Manufacturing Introduction
11.20.4 Novavax, Inc. Revenue in Human Vaccine Contract Manufacturing Business (2019-2024)
11.20.5 Novavax, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Government
Lonza
FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
Ajinomoto Althea, Inc.
Merck KGaA
Cytovance Biologics
Catalent
IDT Biologika GmbH
Albany Molecular Research Inc
PRA Health Sciences
ICON
Pharmaceutical Product Development LLC
Cobra Bio
Paragon Bioservices, Inc.
Emergent BioSolutions Inc
CSL Limited
BioNTech SE
Wuxi Biologics
Samsung Biologics
Boehringer Ingelheim
Novavax Inc
List of Tables
 Table 1. Global Human Vaccine Contract Manufacturing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Attenuated
 Table 3. Key Players of Inactivated
 Table 4. Key Players of Subunit-based
 Table 5. Key Players of Toxoid-based
 Table 6. Key Players of DNA-based
 Table 7. Global Human Vaccine Contract Manufacturing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 8. Global Human Vaccine Contract Manufacturing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 9. Global Human Vaccine Contract Manufacturing Market Size by Region (2019-2024) & (US$ Million)
 Table 10. Global Human Vaccine Contract Manufacturing Market Share by Region (2019-2024)
 Table 11. Global Human Vaccine Contract Manufacturing Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 12. Global Human Vaccine Contract Manufacturing Market Share by Region (2025-2030)
 Table 13. Human Vaccine Contract Manufacturing Market Trends
 Table 14. Human Vaccine Contract Manufacturing Market Drivers
 Table 15. Human Vaccine Contract Manufacturing Market Challenges
 Table 16. Human Vaccine Contract Manufacturing Market Restraints
 Table 17. Global Human Vaccine Contract Manufacturing Revenue by Players (2019-2024) & (US$ Million)
 Table 18. Global Human Vaccine Contract Manufacturing Market Share by Players (2019-2024)
 Table 19. Global Top Human Vaccine Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Vaccine Contract Manufacturing as of 2023)
 Table 20. Ranking of Global Top Human Vaccine Contract Manufacturing Companies by Revenue (US$ Million) in 2023
 Table 21. Global 5 Largest Players Market Share by Human Vaccine Contract Manufacturing Revenue (CR5 and HHI) & (2019-2024)
 Table 22. Global Key Players of Human Vaccine Contract Manufacturing, Headquarters and Area Served
 Table 23. Global Key Players of Human Vaccine Contract Manufacturing, Product and Application
 Table 24. Global Key Players of Human Vaccine Contract Manufacturing, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Human Vaccine Contract Manufacturing Market Size by Type (2019-2024) & (US$ Million)
 Table 27. Global Human Vaccine Contract Manufacturing Revenue Market Share by Type (2019-2024)
 Table 28. Global Human Vaccine Contract Manufacturing Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 29. Global Human Vaccine Contract Manufacturing Revenue Market Share by Type (2025-2030)
 Table 30. Global Human Vaccine Contract Manufacturing Market Size by Application (2019-2024) & (US$ Million)
 Table 31. Global Human Vaccine Contract Manufacturing Revenue Market Share by Application (2019-2024)
 Table 32. Global Human Vaccine Contract Manufacturing Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 33. Global Human Vaccine Contract Manufacturing Revenue Market Share by Application (2025-2030)
 Table 34. North America Human Vaccine Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 35. North America Human Vaccine Contract Manufacturing Market Size by Country (2019-2024) & (US$ Million)
 Table 36. North America Human Vaccine Contract Manufacturing Market Size by Country (2025-2030) & (US$ Million)
 Table 37. Europe Human Vaccine Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 38. Europe Human Vaccine Contract Manufacturing Market Size by Country (2019-2024) & (US$ Million)
 Table 39. Europe Human Vaccine Contract Manufacturing Market Size by Country (2025-2030) & (US$ Million)
 Table 40. Asia-Pacific Human Vaccine Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 41. Asia-Pacific Human Vaccine Contract Manufacturing Market Size by Region (2019-2024) & (US$ Million)
 Table 42. Asia-Pacific Human Vaccine Contract Manufacturing Market Size by Region (2025-2030) & (US$ Million)
 Table 43. Latin America Human Vaccine Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 44. Latin America Human Vaccine Contract Manufacturing Market Size by Country (2019-2024) & (US$ Million)
 Table 45. Latin America Human Vaccine Contract Manufacturing Market Size by Country (2025-2030) & (US$ Million)
 Table 46. Middle East & Africa Human Vaccine Contract Manufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 47. Middle East & Africa Human Vaccine Contract Manufacturing Market Size by Country (2019-2024) & (US$ Million)
 Table 48. Middle East & Africa Human Vaccine Contract Manufacturing Market Size by Country (2025-2030) & (US$ Million)
 Table 49. Lonza Company Details
 Table 50. Lonza Business Overview
 Table 51. Lonza Human Vaccine Contract Manufacturing Product
 Table 52. Lonza Revenue in Human Vaccine Contract Manufacturing Business (2019-2024) & (US$ Million)
 Table 53. Lonza Recent Development
 Table 54. Fujifilm Diosynth Biotechnologies U.S.A., Inc. Company Details
 Table 55. Fujifilm Diosynth Biotechnologies U.S.A., Inc. Business Overview
 Table 56. Fujifilm Diosynth Biotechnologies U.S.A., Inc. Human Vaccine Contract Manufacturing Product
 Table 57. Fujifilm Diosynth Biotechnologies U.S.A., Inc. Revenue in Human Vaccine Contract Manufacturing Business (2019-2024) & (US$ Million)
 Table 58. Fujifilm Diosynth Biotechnologies U.S.A., Inc. Recent Development
 Table 59. Ajinomoto Althea, Inc. Company Details
 Table 60. Ajinomoto Althea, Inc. Business Overview
 Table 61. Ajinomoto Althea, Inc. Human Vaccine Contract Manufacturing Product
 Table 62. Ajinomoto Althea, Inc. Revenue in Human Vaccine Contract Manufacturing Business (2019-2024) & (US$ Million)
 Table 63. Ajinomoto Althea, Inc. Recent Development
 Table 64. Merck KgaA Company Details
 Table 65. Merck KgaA Business Overview
 Table 66. Merck KgaA Human Vaccine Contract Manufacturing Product
 Table 67. Merck KgaA Revenue in Human Vaccine Contract Manufacturing Business (2019-2024) & (US$ Million)
 Table 68. Merck KgaA Recent Development
 Table 69. Cytovance Biologics Company Details
 Table 70. Cytovance Biologics Business Overview
 Table 71. Cytovance Biologics Human Vaccine Contract Manufacturing Product
 Table 72. Cytovance Biologics Revenue in Human Vaccine Contract Manufacturing Business (2019-2024) & (US$ Million)
 Table 73. Cytovance Biologics Recent Development
 Table 74. Catalent, Inc. Company Details
 Table 75. Catalent, Inc. Business Overview
 Table 76. Catalent, Inc. Human Vaccine Contract Manufacturing Product
 Table 77. Catalent, Inc. Revenue in Human Vaccine Contract Manufacturing Business (2019-2024) & (US$ Million)
 Table 78. Catalent, Inc. Recent Development
 Table 79. IDT Biologika GmbH Company Details
 Table 80. IDT Biologika GmbH Business Overview
 Table 81. IDT Biologika GmbH Human Vaccine Contract Manufacturing Product
 Table 82. IDT Biologika GmbH Revenue in Human Vaccine Contract Manufacturing Business (2019-2024) & (US$ Million)
 Table 83. IDT Biologika GmbH Recent Development
 Table 84. Albany Molecular Research, Inc. Company Details
 Table 85. Albany Molecular Research, Inc. Business Overview
 Table 86. Albany Molecular Research, Inc. Human Vaccine Contract Manufacturing Product
 Table 87. Albany Molecular Research, Inc. Revenue in Human Vaccine Contract Manufacturing Business (2019-2024) & (US$ Million)
 Table 88. Albany Molecular Research, Inc. Recent Development
 Table 89. PRA Health Sciences Company Details
 Table 90. PRA Health Sciences Business Overview
 Table 91. PRA Health Sciences Human Vaccine Contract Manufacturing Product
 Table 92. PRA Health Sciences Revenue in Human Vaccine Contract Manufacturing Business (2019-2024) & (US$ Million)
 Table 93. PRA Health Sciences Recent Development
 Table 94. ICON plc. Company Details
 Table 95. ICON plc. Business Overview
 Table 96. ICON plc. Human Vaccine Contract Manufacturing Product
 Table 97. ICON plc. Revenue in Human Vaccine Contract Manufacturing Business (2019-2024) & (US$ Million)
 Table 98. ICON plc. Recent Development
 Table 99. Pharmaceutical Product Development, LLC Company Details
 Table 100. Pharmaceutical Product Development, LLC Business Overview
 Table 101. Pharmaceutical Product Development, LLC Human Vaccine Contract Manufacturing Product
 Table 102. Pharmaceutical Product Development, LLC Revenue in Human Vaccine Contract Manufacturing Business (2019-2024) & (US$ Million)
 Table 103. Pharmaceutical Product Development, LLC Recent Development
 Table 104. Cobra Bio Company Details
 Table 105. Cobra Bio Business Overview
 Table 106. Cobra Bio Human Vaccine Contract Manufacturing Product
 Table 107. Cobra Bio Revenue in Human Vaccine Contract Manufacturing Business (2019-2024) & (US$ Million)
 Table 108. Cobra Bio Recent Development
 Table 109. Paragon Bioservices, Inc. Company Details
 Table 110. Paragon Bioservices, Inc. Business Overview
 Table 111. Paragon Bioservices, Inc. Human Vaccine Contract Manufacturing Product
 Table 112. Paragon Bioservices, Inc. Revenue in Human Vaccine Contract Manufacturing Business (2019-2024) & (US$ Million)
 Table 113. Paragon Bioservices, Inc. Recent Development
 Table 114. Emergent BioSolutions Inc. Company Details
 Table 115. Emergent BioSolutions Inc. Business Overview
 Table 116. Emergent BioSolutions Inc. Human Vaccine Contract Manufacturing Product
 Table 117. Emergent BioSolutions Inc. Revenue in Human Vaccine Contract Manufacturing Business (2019-2024) & (US$ Million)
 Table 118. Emergent BioSolutions Inc. Recent Development
 Table 119. CSL Limited Company Details
 Table 120. CSL Limited Business Overview
 Table 121. CSL Limited Human Vaccine Contract Manufacturing Product
 Table 122. CSL Limited Revenue in Human Vaccine Contract Manufacturing Business (2019-2024) & (US$ Million)
 Table 123. CSL Limited Recent Development
 Table 124. BioNTech SE Company Details
 Table 125. BioNTech SE Business Overview
 Table 126. BioNTech SE Human Vaccine Contract Manufacturing Product
 Table 127. BioNTech SE Revenue in Human Vaccine Contract Manufacturing Business (2019-2024) & (US$ Million)
 Table 128. BioNTech SE Recent Development
 Table 129. Wuxi Biologics Company Details
 Table 130. Wuxi Biologics Business Overview
 Table 131. Wuxi Biologics Human Vaccine Contract Manufacturing Product
 Table 132. Wuxi Biologics Revenue in Human Vaccine Contract Manufacturing Business (2019-2024) & (US$ Million)
 Table 133. Wuxi Biologics Recent Development
 Table 134. Samsung Biologics Company Details
 Table 135. Samsung Biologics Business Overview
 Table 136. Samsung Biologics Human Vaccine Contract Manufacturing Product
 Table 137. Samsung Biologics Revenue in Human Vaccine Contract Manufacturing Business (2019-2024) & (US$ Million)
 Table 138. Samsung Biologics Recent Development
 Table 139. Boehringer Ingelheim Company Details
 Table 140. Boehringer Ingelheim Business Overview
 Table 141. Boehringer Ingelheim Human Vaccine Contract Manufacturing Product
 Table 142. Boehringer Ingelheim Revenue in Human Vaccine Contract Manufacturing Business (2019-2024) & (US$ Million)
 Table 143. Boehringer Ingelheim Recent Development
 Table 144. Novavax, Inc. Company Details
 Table 145. Novavax, Inc. Business Overview
 Table 146. Novavax, Inc. Human Vaccine Contract Manufacturing Product
 Table 147. Novavax, Inc. Revenue in Human Vaccine Contract Manufacturing Business (2019-2024) & (US$ Million)
 Table 148. Novavax, Inc. Recent Development
 Table 149. Research Programs/Design for This Report
 Table 150. Key Data Information from Secondary Sources
 Table 151. Key Data Information from Primary Sources
 Table 152. Authors List of This Report


List of Figures
 Figure 1. Human Vaccine Contract Manufacturing Picture
 Figure 2. Global Human Vaccine Contract Manufacturing Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Human Vaccine Contract Manufacturing Market Share by Type: 2023 VS 2030
 Figure 4. Attenuated Features
 Figure 5. Inactivated Features
 Figure 6. Subunit-based Features
 Figure 7. Toxoid-based Features
 Figure 8. DNA-based Features
 Figure 9. Global Human Vaccine Contract Manufacturing Market Size by Application (2024-2030) & (US$ Million)
 Figure 10. Global Human Vaccine Contract Manufacturing Market Share by Application: 2023 VS 2030
 Figure 11. Downstream Case Studies
 Figure 12. Upstream Case Studies
 Figure 13. Human Vaccine Contract Manufacturing Report Years Considered
 Figure 14. Global Human Vaccine Contract Manufacturing Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 15. Global Human Vaccine Contract Manufacturing Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 16. Global Human Vaccine Contract Manufacturing Market Share by Region: 2023 VS 2030
 Figure 17. Global Human Vaccine Contract Manufacturing Market Share by Players in 2023
 Figure 18. Global Top Human Vaccine Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Vaccine Contract Manufacturing as of 2023)
 Figure 19. The Top 10 and 5 Players Market Share by Human Vaccine Contract Manufacturing Revenue in 2023
 Figure 20. North America Human Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. North America Human Vaccine Contract Manufacturing Market Share by Country (2019-2030)
 Figure 22. United States Human Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Canada Human Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Europe Human Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. Europe Human Vaccine Contract Manufacturing Market Share by Country (2019-2030)
 Figure 26. Germany Human Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. France Human Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. U.K. Human Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Italy Human Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Russia Human Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Nordic Countries Human Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Asia-Pacific Human Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Asia-Pacific Human Vaccine Contract Manufacturing Market Share by Region (2019-2030)
 Figure 34. China Human Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Japan Human Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. South Korea Human Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Southeast Asia Human Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. India Human Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Australia Human Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Latin America Human Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Latin America Human Vaccine Contract Manufacturing Market Share by Country (2019-2030)
 Figure 42. Mexico Human Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Brazil Human Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Middle East & Africa Human Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Middle East & Africa Human Vaccine Contract Manufacturing Market Share by Country (2019-2030)
 Figure 46. Turkey Human Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Saudi Arabia Human Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. UAE Human Vaccine Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 49. Lonza Revenue Growth Rate in Human Vaccine Contract Manufacturing Business (2019-2024)
 Figure 50. Fujifilm Diosynth Biotechnologies U.S.A., Inc. Revenue Growth Rate in Human Vaccine Contract Manufacturing Business (2019-2024)
 Figure 51. Ajinomoto Althea, Inc. Revenue Growth Rate in Human Vaccine Contract Manufacturing Business (2019-2024)
 Figure 52. Merck KgaA Revenue Growth Rate in Human Vaccine Contract Manufacturing Business (2019-2024)
 Figure 53. Cytovance Biologics Revenue Growth Rate in Human Vaccine Contract Manufacturing Business (2019-2024)
 Figure 54. Catalent, Inc. Revenue Growth Rate in Human Vaccine Contract Manufacturing Business (2019-2024)
 Figure 55. IDT Biologika GmbH Revenue Growth Rate in Human Vaccine Contract Manufacturing Business (2019-2024)
 Figure 56. Albany Molecular Research, Inc. Revenue Growth Rate in Human Vaccine Contract Manufacturing Business (2019-2024)
 Figure 57. PRA Health Sciences Revenue Growth Rate in Human Vaccine Contract Manufacturing Business (2019-2024)
 Figure 58. ICON plc. Revenue Growth Rate in Human Vaccine Contract Manufacturing Business (2019-2024)
 Figure 59. Pharmaceutical Product Development, LLC Revenue Growth Rate in Human Vaccine Contract Manufacturing Business (2019-2024)
 Figure 60. Cobra Bio Revenue Growth Rate in Human Vaccine Contract Manufacturing Business (2019-2024)
 Figure 61. Paragon Bioservices, Inc. Revenue Growth Rate in Human Vaccine Contract Manufacturing Business (2019-2024)
 Figure 62. Emergent BioSolutions Inc. Revenue Growth Rate in Human Vaccine Contract Manufacturing Business (2019-2024)
 Figure 63. CSL Limited Revenue Growth Rate in Human Vaccine Contract Manufacturing Business (2019-2024)
 Figure 64. BioNTech SE Revenue Growth Rate in Human Vaccine Contract Manufacturing Business (2019-2024)
 Figure 65. Wuxi Biologics Revenue Growth Rate in Human Vaccine Contract Manufacturing Business (2019-2024)
 Figure 66. Samsung Biologics Revenue Growth Rate in Human Vaccine Contract Manufacturing Business (2019-2024)
 Figure 67. Boehringer Ingelheim Revenue Growth Rate in Human Vaccine Contract Manufacturing Business (2019-2024)
 Figure 68. Novavax, Inc. Revenue Growth Rate in Human Vaccine Contract Manufacturing Business (2019-2024)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Biopharmaceutical CMO Services Market Research Report 2024
Global Pharmaceutical CMO Services Market Research Report 2024
Vaccine Contract Manufacturing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Healthcare Contract Development And Manufacturing Organization Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmaceutical Products and CMO Market Research Report 2024
Pharmaceutical Contract Manufacturing and Contract Market
Global Contract Pharmaceutical Manufacturing Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Contract Bio manufacturing Organization CMO Market Insights Forecast to 2030
Global Biotechnology Contract Manufacturing Market Research Report 2024
Global Human Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Healthcare Contract Manufacturing Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Healthcare Device Contract Manufacturing Market
Global Pharmaceutical Contract Development and Manufacturing Market Insights Forecast to 2030
Biopharma Contract Manufacturing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Contract Manufacturing Services Market Research Report 2024
Biologics CDMO Market
Global Electronic Contract Manufacturing Market Insights Forecast to 2030
Global CMO CDMO Market Insights Forecast to 2030
Metal Contract Manufacturing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Contract Manufacturing Organization Services Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions